R
Raul D. Santos
Researcher at University of São Paulo
Publications - 463
Citations - 21660
Raul D. Santos is an academic researcher from University of São Paulo. The author has contributed to research in topics: Familial hypercholesterolemia & Medicine. The author has an hindex of 56, co-authored 404 publications receiving 16997 citations. Previous affiliations of Raul D. Santos include Albert Einstein Hospital.
Papers
More filters
Journal ArticleDOI
Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system.
TL;DR: The economic impact of hospitalizations due to CAD attributable to FH in the Brazilian Unified Health Care System (SUS) from 2012--2014 was estimated to be R$ 985,919,064, of which R$ 29,053,500 and R$ 51,764,175, respectively, were Estimated to be attributable toFH.
Journal ArticleDOI
Coronary calcification and coronary heart disease death rates in different countries, not only the influence of classical risk factors.
Journal ArticleDOI
Reaching C-Reactive Protein and Low-Density Lipoprotein Cholesterol Goals in Dyslipidemic Patients (from the Lipid Treatment Assessment Project [L-TAP] 2)
Cheng-Wen Chiang,Raul D. Santos,David D. Waters,Michael Messig,Lisa Tarasenko,J. Wouter Jukema,Jean Ferrières,JoAnne M. Foody,Ki-Bae Seung +8 more
TL;DR: With current treatment, most dyslipidemic patients do not reach the dual CRP and LDL cholesterol goals, and smoking cessation, weight reduction, and the greater use of more potent statins at higher doses might be able to improve these outcomes.
Journal ArticleDOI
Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia.
Pãmela Rodrigues de Souza Silva,Cinthia E. Jannes,Theo G M Oliveira,Luz Marina Gomez Gomez,José Eduardo Krieger,Raul D. Santos,Alexandre C. Pereira +6 more
TL;DR: The data suggest that FH cascade screening programs can predict family enrollment based on IC features, and this information may be useful for devising better and more effective screening approaches for at-risk individuals.
Journal ArticleDOI
Uric acid and cardiovascular disease: how to solve another chicken or egg puzzle.
TL;DR: A post hoc analysis of the Bezafibrate Infarction Prevention trial suggests that increased SUA is an independent marker of cardiovascular disease even for subjects at an already higher risk of event recurrence.